Simplex Trading
ADCT icon

Simplex Trading’s ADC Therapeutics ADCT Stock Holding History

Simplex Trading’s Portfolio ADCT Stock Details ADCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.1K Buy
8,300
+7,700
+1,283% +$30.4K ﹤0.01% 6349
2025
Q4 		$2.12K Buy
600
+300
+100% +$1.22K ﹤0.01% 7815
2025
Q3 		$1K Sell
300
-6,800
-96% -$21.4K ﹤0.01% 8756
2025
Q2 		$19K Buy
+7,100
New +$14.9K ﹤0.01% 6792
2025
Q1 		– Sell
-2,000
Closed -$3K – 8386
2024
Q4 		$3K Buy
2,000
+600
+43% +$1.57K ﹤0.01% 7817
2024
Q3 		$4K Sell
1,400
-35,800
-96% -$113K ﹤0.01% 7679
2024
Q2 		$117K Buy
37,200
+22,400
+151% +$89K ﹤0.01% 5208
2024
Q1 		$66K Buy
+14,800
New +$54.6K ﹤0.01% 5995
2023
Q3 		– Sell
-2,100
Closed -$4K – 8533
2023
Q2 		$4K Sell
2,100
-2,000
-49% -$4.5K ﹤0.01% 7996
2023
Q1 		$7K Buy
+4,100
New +$15.1K ﹤0.01% 7779
2022
Q4 		– Sell
-5,100
Closed -$24K – 9067
2022
Q3 		$24K Hold
5,100
– – ﹤0.01% 7307
2022
Q2 		$40K Buy
5,100
+100
+2% +$946 ﹤0.01% 6755
2022
Q1 		$73K Buy
5,000
+3,200
+178% +$50.8K ﹤0.01% 6582
2021
Q4 		$36K Sell
1,800
-2,000
-53% -$48.2K ﹤0.01% 7652
2021
Q3 		$93K Hold
3,800
– – ﹤0.01% 6715
2021
Q2 		$92K Buy
3,800
+3,769
+12,158% +$87.5K ﹤0.01% 6851
2021
Q1 		$75K Buy
+31
New +$898 ﹤0.01% 6123
2020
Q4 		– Sell
-1
Closed -$3K – 8243
2020
Q3 		$3K Buy
+1
New +$43 ﹤0.01% 7258

Other funds holding ADCT

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Simplex Trading's ADCT Position: Q1 2026 in Review

Simplex Trading sold out of ADC Therapeutics (ADCT) in Q1 2026, closing a stake of 2,687 shares — an estimated $10.6K sold.

Simplex Trading first reported a position in ADCT in Q3 2020 and held it in 17 quarters. The position peaked at $66K in Q1 2024. 118 funds tracked by Wall St. Rank hold ADCT as of Q1 2026.

  • Simplex Trading reported no remaining ADC Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 2,687 ADC Therapeutics shares in Q1 2026, an estimated $10.6K.
  • Simplex Trading first reported a position in ADC Therapeutics in Q3 2020 and held it in 17 quarters.
  • Simplex Trading's ADC Therapeutics position peaked at $66K in Q1 2024.
  • 118 funds tracked by Wall St. Rank held ADC Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.